Martha Bulyk

Professor of Medicine and Pathology; Louis and Elizabeth Maas Endowed Chair in Genomic Medicine; Co-Chair, Harvard Biophysics Graduate Program

Brigham and Women's Hospital
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Positions (1)

Publisher
source

Martha Bulyk

University Name
.

Brigham & Women's Hospital

Martha Bulyk is advertising 2 postdoctoral openings in the Bulyk Lab at the Division of Genetics, Brigham & Women’s Hospital , within the Harvard Medical School research community in Boston, Massachusetts, United States. The project focuses on transcriptional gene regulation and human transcription factor-DNA interactions , with an emphasis on understanding the effects of coding variation in transcription factors . The work will combine biochemical , cell culture-based , and computational approaches. Applicants should have a recent Ph.D. (2025 or 2026) , or be scheduled to graduate in Fall 2026 , in a biological field . The post also asks for strong quantitative skills and prior programming experience . Candidates with both experimental and computational experience are especially relevant. This is a postdoctoral opportunity rather than a scholarship or degree program. Funding details are not specified in the post. For full information and application instructions, use the linked posting.

2 months ago

Articles (16)

Year:

2025

Most genetic loci associated with complex traits and diseases through genome-wide association studies (GWAS) are noncoding, suggesting that the causal variants likely have gene regulatory effects. However, only a small number of loci have been linked to expression quantitative trait loci (eQTLs) detected currently. To better understand the potential reasons for many trait-associated loci lacking eQTL colocalization, we investigated whether chromatin accessibility QTLs (caQTLs) in lymphoblastoid cell lines (LCLs) explain immune-mediated disease associations that eQTLs in LCLs did not. The power to detect caQTLs was greater than that of eQTLs and was less affected by the distance from the transcription start site of the associated gene. Meta-analyzing LCL eQTL data to increase the sample size to over a thousand led to additional loci with eQTL colocalization, demonstrating that insufficient statistical power is still likely to be a factor. Moreover, further eQTL colocalization loci were uncovered by surveying eQTLs of other immune cell types. Altogether, insufficient power and context specificity of eQTLs both contribute to the ‘missing regulation’.

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Most genetic loci associated with complex traits and diseases through genome-wide association studies (GWAS) are noncoding, suggesting that the causal variants likely have gene regulatory effects. However, only a small number of loci have been linked to expression quantitative trait loci (eQTLs) detected currently. To better understand the potential reasons for many trait-associated loci lacking eQTL colocalization, we investigated whether chromatin accessibility QTLs (caQTLs) in lymphoblastoid cell lines (LCLs) explain immune-mediated disease associations that eQTLs in LCLs did not. The power to detect caQTLs was greater than that of eQTLs and was less affected by the distance from the transcription start site of the associated gene. Meta-analyzing LCL eQTL data to increase the sample size to over a thousand led to additional loci with eQTL colocalization, demonstrating that insufficient statistical power is still likely to be a factor. Moreover, further eQTL colocalization loci were uncovered by surveying eQTLs of other immune cell types. Altogether, insufficient power and context specificity of eQTLs both contribute to the ‘missing regulation’.

Year:

2025

Viral transcriptional regulators (vTRs) reprogram host gene regulatory networks to promote replication, persistence, and immune evasion. Despite the identification of hundreds of vTRs in human viruses, how they rewire host pathways remains unclear. Here, we systematically profiled 95 vTRs from diverse human viruses across multiple functional assays. vTRs perturb immune, cell proliferation/death, and signaling pathways through various mechanisms; some bind DNA directly, others cooperate or antagonize human transcription factors (hTFs), and some remodel chromatin. vTRs can act as activators or repressors and recruit similar but not identical repertoires of proteins as hTFs. These findings reveal vTRs as versatile transcriptional modulators that converge on conserved host “pressure points” while diversifying across pathways to promote viral replication and persistence. Notably, many vTR dysregulate genes within autoimmune, neurological, and cardiovascular risk loci, revealing mechanistic links to disease. Together, we provide a comprehensive resource for understanding and targeting viral control of human transcription.

Year:

2025

Most genetic loci associated with complex traits and diseases through genome-wide association studies (GWAS) are noncoding, suggesting that the causal variants likely have gene regulatory effects. However, only a small number of loci have been linked to expression quantitative trait loci (eQTLs) detected currently. To better understand the potential reasons for many trait-associated loci lacking eQTL colocalization, we investigated whether chromatin accessibility QTLs (caQTLs) in lymphoblastoid cell lines (LCLs) explain immune-mediated disease associations that eQTLs in LCLs did not. The power to detect caQTLs was greater than that of eQTLs and was less affected by the distance from the transcription start site of the associated gene. Meta-analyzing LCL eQTL data to increase the sample size to over a thousand led to additional loci with eQTL colocalization, demonstrating that insufficient statistical power is still likely to be a factor. Moreover, further eQTL colocalization loci were uncovered by surveying eQTLs of other immune cell types. Altogether, insufficient power and context-specificity of eQTLs both contribute to the ’missing regulation.’

Year:

2025

Congenital heart defects (CHD) occur in ∼1% of live births, with both inherited and acquired mutations and environmental factors known to contribute to causation. However, network perturbations and epigenetic changes in CHD remain poorly characterised. We report an integrated functional-epigenomics approach to understanding CHD, focusing on the cardiac homeodomain (HD) family transcription factor NKX2-5, mutations in which cause diverse congenital heart structural and conduction defects. We selected twelve NKX2-5 CHD-associated variants affecting different residue classes - DNA base-contacting, backbone-contacting, helix-stabilizing residues of the homeodomain, and those affecting other conserved protein:protein interaction (PPI) domains. In HL-1 cardiomyocytes, we profiled DNA targets of NKX2-5 wild type (WT) and variant proteins genome-wide using DamID, their DNA binding affinity and specificity using comprehensive protein binding microarrays, and PPI with known NKX2-5 cofactors using yeast 2-hybrid assay. We also undertook deep profiling of chromatin search and binding dynamics using single molecule tracking. Variants showed highly diverse but also class-specific behaviours with a range of severities. All variants failed to bind many WT targets but retained binding to a subset of core cardiomyocyte-related WT NKX2-5 targets, as well as hundreds of unique “off-targets”, in part via a regulatory logic that included changes to DNA binding site specificity, homodimerization and lost or enhanced cofactor interactions. All variants tested showed altered chromatin search functions. Our data suggest that complex residue-by-residue scale epigenomic, biochemical and chromatin search perturbations, involving both loss- and gain-of-function, contribute to CHD phenotypes. These findings may inform precision molecular therapeutic approaches in patients with CHD.

Year:

2025

Recognition of specific DNA sequences by transcription factors (TFs) is a key step in transcriptional control of gene expression. While most forkhead (FH) TFs bind either an FKH (RYAAAYA) or an FHL (GACGC) recognition motif, some FHs can bind both motifs. Mechanisms that control whether a FH is monospecific versus bispecific have remained unknown. Screening a library of 12 reference FH proteins, 61 naturally occurring missense variants including clinical variants, and 22 designed mutant FHs for DNA binding activity using universal (“all 10-mer”) protein binding microarrays (PBMs) revealed non-DNA-contacting residues that control mono- versus bispecificity. Variation in non-DNA-contacting amino acid residues of TFs is associated with human traits and may play a role in the evolution of TF DNA binding activities and gene regulatory networks. Highlights Most forkhead (FH) proteins recognize FKH or FHL motifs, while others are bispecific DNA binding activities of 12 reference and 83 variant or designed FHs Clinical or population FH variants with altered DNA binding affinity or specificity Non-DNA-contacting amino acid residues synergistically control mono- versus bi- specificity

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Collaborators (12)

Sally Dunwoodie

Head, Embryology and Congenital Heart Disease Research

Victor Chang Cardiac Research Institute

AUSTRALIA
View details

Frédéric A Meunier

-

AUSTRALIA
View details

Mathias Francois

Lab Head

University of Sydney

AUSTRALIA
View details

Ying Liu

Assistant Professor

Northwell Health

UNITED STATES
View details

Jean-Claude TWIZERE

Associate Professor

University of Liege

BELGIUM
View details

Nathan Salomonis

Professor

Cincinnati Children's Hospital Medical Center

UNITED STATES
View details

Juan Fuxman Bass

Boston University

UNITED STATES
View details

Kwangwoon Lee

Assistant Professor

Ohio State University

UNITED STATES
View details

Richard Harvey

Deputy Director Victor Chang Institute, Head of Cardiac Developmental and Stem Cell Biology Division; Professor of Heart Research, University of New South Wales, Australia

Victor Chang Cardiac Research Institute

AUSTRALIA
View details

Mirana Ramialison

Head of the Transcriptomics and Bioinformatics Group

Murdoch Childrens Research Institute

AUSTRALIA
View details

Toby Hunt

European Bioinformatics Institute

UNITED KINGDOM
View details

Norbert Perrimon

James Stillman Professor of Developmental Biology

Harvard University

UNITED STATES
View details